Cargando...
Pharmacodynamics, safety, and immunogenicity of Pelmeg(®), a pegfilgrastim biosimilar in healthy subjects
A pharmacodynamics (PD) and immunogenicity study was conducted to investigate biosimilarity of Pelmeg(®), a pegfilgrastim biosimilar to EU‐authorized Neulasta(®). The multiple‐dose, randomized, double‐blind, two‐sequence, and three‐period cross‐over study comprised 96 healthy male subjects, receivin...
Guardado en:
| Publicado en: | Pharmacol Res Perspect |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6691755/ https://ncbi.nlm.nih.gov/pubmed/31417681 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.507 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|